ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Sep 14, 2021 17:46 JST
Source: Eisai
Eisai to Join The Global Environmental Initiative "RE100"
TOKYO, Sep 14, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has joined "RE100", the global environmental initiative that aims to shift the electricity used in business activities to 100% renewable electricity.
RE100 is an initiative committed to shifting the electricity used in business activities to 100% renewable energy with the aim of realizing a carbon-free society, and about 300 companies have joined worldwide. The Climate Group, an international environmental NGO, operates RE100 in partnership with CDP.
In May 2021, Eisai declared that it would achieve carbon neutrality in 2040 as a long-term goal for greenhouse gas (GHG) reduction. In addition, Eisai aims to increase the renewable energy usage rate of electricity throughout the Eisai Group to 100% by 2030 as its medium-term goal. With the accession to RE100, Eisai will accelerate its efforts to achieve the goals, promoting the use of solar power generation based on the PPA (Power Purchase Agreement) model and installing power generation equipment using natural energy in addition to the promotion of energy conservation and renewable energy utilization that has been carried out in Eisai.
Regarding Eisai's accession to RE100, Sam Kimmins, Head of RE100 at Climate Group said: "We are delighted that Eisai has joined RE100 the global initiative led by the Climate Group in partnership with CDP. By committing to 100% renewable electricity by 2030, Eisai is taking leadership in climate action. They join more than 50 Japanese RE100 companies who collectively, send a powerful message that renewable electricity makes good business sense."
Eisai's corporate philosophy is to give first thought to patients and their families, and increase the benefits that health care provides, and Eisai calls this philosophy the "human health care (hhc)" philosophy, in one word. To realize this hhc philosophy, Eisai will further strengthen its activities to ensure the sustainability of the global environment, which is the basis of its business activities.
For more detailed information about Eisai's environmental activities, please visit
https://www.eisai.com/sustainability/environment/index.html
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Sectors: Environment, ESG, BioTech
Copyright ©2022 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Mitsubishi Corporation: Seven-Member Partnership Commits to Warehouse DX Initiative
Jul 01, 2022 16:10 JST
NEC Expands Global Solutions Delivery Capacity with Acquisition of Aspire Technology, a Network Solutions and System Integration Company
Jul 01, 2022 12:47 JST
MC and Maruha Nichiro Agree to Establish New Joint Venture in Salmon (land-based)
Jun 30, 2022 18:23 JST
DOCOMO and CyberAgent to Establish New Advertising Company: Prism Partner Inc.
Jun 30, 2022 18:04 JST
MHIENG's First Compact CO2 Capture System Goes into Commercial Operation at Biomass Power Plant in Hiroshima
Jun 30, 2022 14:44 JST
Mazda Production and Sales Results for May 2022
Jun 30, 2022 13:33 JST
Milestone of THz Communication
Jun 29, 2022 16:48 JST
Infinera and NEC to Modernize Neutral Networks' Mexico to United States Fiber Optic Network with Industry-leading ICE6 800G Solution
Jun 29, 2022 15:35 JST
Fujitsu Recognized as Winner of 2022 Microsoft Education Partner of the Year Award
Jun 29, 2022 11:18 JST
Hitachi High-Tech Launches the AFM100 Pro High-Sensitivity Scanning Probe Microscope System with Improved Detection Sensitivity
Jun 28, 2022 16:51 JST
Hokkaido University and NEC conclude an agreement for developing spatial sensing to combat the spread of illness
Jun 28, 2022 15:53 JST
Fujitsu global survey demonstrates how 'digital first' approach helps to accelerate sustainability transformation
Jun 28, 2022 12:26 JST
E.Design Insurance and Eisai Enter Into Business Alliance
Jun 28, 2022 10:20 JST
GR YARIS Rally1 wins African epic with incredible 1-2-3-4 finish
Jun 27, 2022 10:50 JST
Toyota and Suzuki to Deepen Collaboration in the Fields of Development and Production in India
Jun 24, 2022 19:16 JST
Murata and Mitsubishi Agree on a Cooperative Framework for Working Toward a Carbon-Neutral Society
Jun 24, 2022 18:22 JST
Eisai Signs the Public-Private Partnership "Kigali Declaration" for Eliminating Neglected Tropical Diseases
Jun 24, 2022 11:55 JST
Honda Joins Sustainable Aviation Fuel Review Panel
Jun 24, 2022 10:42 JST
TOYOTA GAZOO Racing announces team setup for Nurburgring Endurance Series
Jun 23, 2022 17:54 JST
MHI Invests in Electric Hydrogen, a U.S. Startup, to Accelerate Efforts to Produce Clean Hydrogen at Scale
Jun 23, 2022 14:31 JST
More Latest Release >>
Related Release
E.Design Insurance and Eisai Enter Into Business Alliance
6/28/2022 10:20:00 AM JST
Eisai Signs the Public-Private Partnership "Kigali Declaration" for Eliminating Neglected Tropical Diseases
6/24/2022 11:55:00 AM JST
Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer-Reviewed Neurology and Therapy Journal
6/22/2022 2:05:00 PM JST
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
6/6/2022 3:05:00 PM JST
Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting
6/3/2022 4:37:00 PM JST
Eisai Contributes to the Science of Cancer Medicine at ASCO 2022
5/27/2022 12:49:00 PM JST
Eisai: MHLW Grants Orphan Drug Designation in Japan to Mecobalamin Ultrahigh-Dose Formulation with Prospective Indication for Delaying the Progression of Disease and Functional Impairment of ALS
5/27/2022 12:24:00 PM JST
Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer's Disease Under the Accelerated Approval Pathway
5/10/2022 11:23:00 AM JST
Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan
5/10/2022 11:00:00 AM JST
Eisai Announces Acquisition of Arteryex Shares (Making Arteryex a Subsidiary) to Strengthen and Rapidly Expand the Foundation of its Digital Solution Business
4/1/2022 2:05:00 PM JST
More Press release >>